Fairvalue-Calculator Fairvalue-Calculator
EN DE

Bonraybio Co (6955) Fair Value & Analysis

Healthcare · TW · Market cap 3.4B TWD

Price127.50 TWD
Fair Value77.59 TWD
Upside-39.1%
Quality95/100
Evidence: High Range 55.74 TWD – 102.77 TWD

Fair value as of: Jun 24, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

Bonraybio Co (6955) currently trades at 127.50 TWD, while our model-based Fair Value estimate is 77.59 TWD — implying the stock looks roughly 39.1% overvalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).

About the company

Bonraybio Co., Ltd., a development stage company, manufactures medical instruments and solutions for the male infertility market. The company provides LensHooke X12 PRO semen analysis systems; and LensHooke X1 PRO semen quality analyzers. It also provides consumables, such as CS3 semen test slides; CA0/CA1 sperm separation solutions; and CS1 semen test cassettes. In addition, the company provides X QC Reticles, X QC video tools, and X QC beads; sperm DNA fragmentation test kits; and S10 data consolidation software. Bonraybio Co., Ltd. was founded in 2015 and is based in Taichung, Taiwan.

Open the full interactive analysis →

Similar stocks

Abbott Laboratories, (ABT) -95% Stryker Corporation (S1YK34) -45% Medtronic plc (MDT) -27% Boston Scientific Corporation (B1SX34) -11% Edwards Lifesciences Corporation (EW) -52% Siemens Healthineers AG (SEMHF) +11%

Frequently asked questions

Is Bonraybio Co (6955) undervalued?
As of Jun 24, 2026, our model estimates a fair value of 77.59 TWD versus a price of 127.50 TWD — about −39% (overvalued). Model-based estimate, not financial advice.
What is the fair value of 6955?
Our 21-model fair value for Bonraybio Co is 77.59 TWD (as of Jun 24, 2026), built from audited fundamentals. The current price is 127.50 TWD.
What is the quality score of 6955?
Bonraybio Co has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.